Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003492962 | SCV004234993 | uncertain significance | Anemia, congenital dyserythropoietic, type 1a | 2023-07-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004364874 | SCV004922328 | uncertain significance | Inborn genetic diseases | 2024-01-29 | criteria provided, single submitter | clinical testing | The c.1606G>C (p.A536P) alteration is located in exon 11 (coding exon 11) of the CDAN1 gene. This alteration results from a G to C substitution at nucleotide position 1606, causing the alanine (A) at amino acid position 536 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |